distribution kinetics
Recently Published Documents


TOTAL DOCUMENTS

163
(FIVE YEARS 7)

H-INDEX

29
(FIVE YEARS 1)

Antioxidants ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 1083
Author(s):  
Anallely López-Yerena ◽  
Anna Vallverdú-Queralt ◽  
Rosa M. Lamuela-Raventós ◽  
Elvira Escribano-Ferrer

The purpose of this work was to study the distribution of oleacein (OLEA) and its metabolites in rat plasma and different tissues, namely brain, heart, kidney, liver, lung, small intestine, spleen, stomach, skin, and thyroid, following the acute intake of a refined olive oil containing 0.3 mg/mL of OLEA. For this purpose, a distribution kinetics study was carried out. The plasma and tissues were collected at 1, 2, and 4.5 h after the intervention, and analyzed by LC-ESI-LTQ-Orbitrap-MS. Unmetabolized OLEA was detected in the stomach, small intestine, liver, plasma and, most notably, the heart. This finding may be useful for the development of new applications of OLEA for cardiovascular disease prevention. Noteworthy are also the high levels of hydroxytyrosol (OH-TY) and OLEA + CH3 found in the small intestine, liver, and plasma, and the detection of nine OLEA metabolites, five of them arising from conjugation reactions. Liver, heart, spleen, and lungs were the target tissues where the metabolites were most distributed. However, it is important to note that OH-TY, in our experimental conditions, was not detected in any target tissue (heart, spleen, thyroids, lungs, brain, and skin). These results shed further light on the metabolism and tissue distribution of OLEA and contribute to understanding the mechanisms underlying its effect in human health.


Author(s):  
Roshan Sonkar ◽  
Sonali ◽  
Abhishek Jha ◽  
Matte Kasi Viswanadh ◽  
Ankita Sanjay Burande ◽  
...  

2020 ◽  
Vol 163 ◽  
pp. 104874
Author(s):  
Larissa P. Cunico ◽  
Mingzhe Sun ◽  
Yu Rui ◽  
Semhar Ghirmai ◽  
Markus Enekvist ◽  
...  

Foods ◽  
2020 ◽  
Vol 9 (2) ◽  
pp. 124 ◽  
Author(s):  
Shimshoni ◽  
Bommuraj ◽  
Chen ◽  
Sperling ◽  
Barel ◽  
...  

Postharvest application of fungicides is commonly applied in order to reduce food loss. Prochloraz is currently the only postharvest fungicide registered in Israel and Europe in avocado fruits. Due to its unfavorable toxicological properties, prochloraz will be banned from the end of 2020 for future postharvest usage and therefore a substitute candidate is urgently warranted. Fludioxonil, a relatively safe, wide spectrum fungicide, is approved in Europe and Israel for postharvest use in various fruits, but not avocado. Hence, fludioxonil has been evaluated in the present study as a potential substitute for prochloraz in avocado. The objectives of the present study were to determine fludioxonil efficacy against common fungal infestations in avocado and distribution kinetics between peel and pulp in comparison to prochloraz. At the same concentration range (75–300 µg/L), fludioxonil was as effective as prochloraz in inhibiting postharvest decay, while in the early season cultivars, suffering mainly from stem-end rot, it exhibited a better decay control than prochloraz. Fludioxonil and prochloraz displayed negligible and undetected pulp levels, respectively, due to low peel penetrability. Taken altogether, fludioxonil was found to be a suitable candidate for replacing prochloraz as a postharvest fungicide in avocado.


2019 ◽  
Vol 164 ◽  
pp. 196-201 ◽  
Author(s):  
Hui Kong ◽  
Guiliang Zhang ◽  
Jinjun Cheng ◽  
Rongfeng Shi ◽  
Meiling Zhang ◽  
...  

Molecules ◽  
2017 ◽  
Vol 22 (6) ◽  
pp. 939 ◽  
Author(s):  
Hui Kong ◽  
Xueqian Wang ◽  
Rongfeng Shi ◽  
Yan Zhao ◽  
Jinjun Cheng ◽  
...  

2017 ◽  
Vol 38 (5) ◽  
pp. 904-918 ◽  
Author(s):  
Suresh Kumar Swaminathan ◽  
Kristen M Ahlschwede ◽  
Vidur Sarma ◽  
Geoffry L Curran ◽  
Rajesh S Omtri ◽  
...  

Impaired brain clearance of amyloid-beta peptides (Aβ) 40 and 42 across the blood–brain barrier (BBB) is believed to be one of the pathways responsible for Alzheimer’s disease (AD) pathogenesis. Hyperinsulinemia prevalent in type II diabetes was shown to damage cerebral vasculature and increase Aβ accumulation in AD brain. However, there is no clarity on how aberrations in peripheral insulin levels affect Aβ accumulation in the brain. This study describes, for the first time, an intricate relation between plasma insulin and Aβ transport at the BBB. Upon peripheral insulin administration in wild-type mice: the plasma clearance of Aβ40 increased, but Aβ42 clearance reduced; the plasma-to-brain influx of Aβ40 increased, and that of Aβ42 reduced; and the clearance of intracerebrally injected Aβ40 decreased, whereas Aβ42 clearance increased. In hCMEC/D3 monolayers (in vitro BBB model) exposed to insulin, the luminal uptake and luminal-to-abluminal permeability of Aβ40 increased and that of Aβ42 reduced; the abluminal-to-luminal permeability of Aβ40 decreased, whereas Aβ42 permeability increased. Moreover, Aβ cellular trafficking machinery was altered. In summary, Aβ40 and Aβ42 demonstrated distinct distribution kinetics in plasma and brain compartments, and insulin differentially modulated their distribution. Cerebrovascular disease and metabolic disorders may disrupt this intricate homeostasis and aggravate AD pathology.


Sign in / Sign up

Export Citation Format

Share Document